Lin Yuan invests in a list of pharmaceutical stocks

Lin Yuan has made a blanket allocation for pharmaceutical stocks because he can't see the leaders either, so he buys the whole industry. When he knows who the leader is, he won't buy it and will only hold it like Maotai. In the big health field, Pientzehuang and Dong'ah Gum are also companies like Maotai. Select private equity - check rankings - click a button to chat directly with private equity

What is the news related to Lin Yuan's heavy position in pharmaceutical stocks

①When Lin Yuan chooses a company's stock, he will pay attention to whether such listed companies have addiction-type products. This type of addiction-based product is also known as an addictive product. It enables users to consume repeatedly and make people stay with it, eventually forming a dependence and turning into loyal customers of the addictive products.

②Lin Yuan adheres to the concept of value investment, pursues long-term steady appreciation, and the investment targets are monopolized enterprises with absolute competitive advantages. Lin Yuan said that Pientzehuang's advantage lies in the state's approval of its use of natural musk, which is not only a monopoly, but also a unique pricing power. This coincides with Buffett's most classic investment concept -- the idea of economic franchise.

3 Lin Yuan said he hasn't made a single major mistake in the past 30 years, mainly because his stock purchases have all been profitable in the long run. Lin Yuan emphasizes the reason is its macro and competitive grasp of the industry.

The stock market is risky, so you need to be careful when investing.

To learn more about private equity, it is recommended to download the private equity network APP. private equity network is a digitally-driven socialized financial e-commerce platform; years of deep plowing in the financial field, to focus on the attitude of service to more than 1.8 million investors; its company is the China Securities Regulatory Commission approved by the independent third-party fund sales organizations, a huge number of private equity products, strict access standards, professional service team.